Accenture
ACN · NYSE · Information Technology
+$2.18 today
- Mkt cap $77.72B
- P/E 10.1
- Day $124.42 – $127.83
Confidence
High conviction
The read
Accenture beats EPS estimates by 2.5% but shares plunge nearly 18% on growth concerns
Accenture reported Q3 EPS of $3.80 versus $3.71 estimate, a 2.5% beat, yet shares fell 17.97% amid weak revenue growth worries and oversold technicals. Despite strong valuation and quality metrics, market skepticism on growth persists.
Confidence note: Data includes confirmed EPS beat, clear price reaction, and detailed fundamental metrics supporting interpretation.
What happened
Earnings print
Guidance
Price reaction
Street narrative
So what
What changed
What the market is pricing
Fundamental takeaway
Next 30–90 days
Revenue growth accelerates above sector average, validating valuation and driving share recovery.
- boltNext quarterly revenue growth above 10% YoY
- boltPositive margin expansion guidance
Steady but below-sector growth continues with stable margins, maintaining current valuation discount.
- boltRevenue growth between 5-7% YoY
- boltStable operating margins
Growth disappoints further, leading to continued share price weakness and valuation multiple contraction.
- boltRevenue growth below 3% YoY
- boltNegative margin guidance or integration issues
What to do
If you hold it
If you're watching
Keep on your radar
- Next quarterly revenue growth rate (due Q3 2026)
- Operating margin guidance updates
- RSI technical recovery above 30
- Institutional ownership changes